Literature DB >> 7890532

Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.

S F Leavey1, H Holloway, M G Courtney, B E Lane, D Royston, K D Buchanan, J F Fielding.   

Abstract

Two patients are reported who presented with symptoms characteristic of a pancreatic vipoma. The necessity to measure more than one plasma VIP level for diagnosis, and the delay between the onset of illness and diagnosis is illustrated by both cases. Evidence suggests that vipomas are still under reported. The evolution of sophisticated diagnostic and therapeutic modalities over the twenty-five years separating both presentations is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890532     DOI: 10.1007/bf02968112

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  16 in total

Review 1.  The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors:  S W Lamberts; E P Krenning; J C Reubi
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

2.  The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985.

Authors:  R G Watson; C F Johnston; M M O'Hare; J R Anderson; B G Wilson; J S Collins; J M Sloan; K D Buchanan
Journal:  Q J Med       Date:  1989-07

3.  Effects of acute metabolic acidosis on parathyroid hormone action and calcium mobilization.

Authors:  N Beck; S K Webster
Journal:  Am J Physiol       Date:  1976-01

4.  Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases.

Authors:  J V Verner; A B Morrison
Journal:  Arch Intern Med       Date:  1974-03

5.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

6.  Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3',5'-monophosphate-dependent mechanism.

Authors:  E L Hohmann; L Levine; A H Tashjian
Journal:  Endocrinology       Date:  1983-04       Impact factor: 4.736

7.  Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.

Authors:  C G Moertel; J A Hanley; L A Johnson
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

8.  Therapy of malignant APUD cell tumors. Effectiveness of DTIC.

Authors:  A Kessinger; J F Foley; H M Lemon
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

9.  Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases.

Authors:  C Capella; J M Polak; R Buffa; F J Tapia; P Heitz; L Usellini; S R Bloom; E Solcia
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

10.  Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon.

Authors:  B Eriksson; K Oberg; G Alm; A Karlsson; G Lundqvist; T Andersson; E Wilander; L Wide
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

View more
  2 in total

Review 1.  Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?

Authors:  Johann Dréanic; Céline Lepère; Mostafa El Hajjam; Hervé Gouya; Philippe Rougier; Romain Coriat
Journal:  Ther Adv Med Oncol       Date:  2016-07-05       Impact factor: 8.168

Review 2.  Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options.

Authors:  H N Nguyen; B Backes; F Lammert; J Wildberger; R Winograd; N Busch; H Rieband; S Matern
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.